In the absence of an actual biotech buyout to report, speculation will have to do. Bloomberg put the spotlight on Clovis Oncology, which reportedly tried to sell itself a couple of years ago–a mention of which usually causes Clovis CEO Patrick Mahaffy’s eyes to start rolling. Why Clovis?

…read more

Source: Take two: Is Clovis Oncology a buyout target?


0 No comments